Volume 2 | Issue 2 | DOI: https://doi.org/10.33696/Neurol.2.039
Primary Angiitis of the Central Nervous System (PACNS): A Commentary on a Proposed Screening Algorithm and an Update on Diagnosis and Treatment
- 1Neurology Department, Stroke Unit, Città di Castello Hospital, USL Umbria 1, Perugia, Italy
- 2IRCCS C. Mondino Foundation, Pavia, Italy
- 3NEUROFARBA Department, Neuroscience Section, University of Florence, Italy
Cristina Sarti, firstname.lastname@example.org
Received Date: April 26, 2021
Accepted Date: May 14, 2021
Picchioni A, Telese R, Failli Y, Sarti C. Primary Angiitis of the Central Nervous System (PACNS): A Commentary on a Proposed Screening Algorithm and an Update on Diagnosis and Treatment. J Exp Neurol. 2021;2(2):76-80
Copyright: © 2021 Picchioni A, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Primary Angitiis, Central Nervous System, Vasculitis, Magnetic Resonance, Diagnosis, Histology
The etiology of fetal growth restriction is rooted in inadequate maternal-placental vascular malperfusion (MVM) of the placenta. Risk factors for MVM are broad and include maternal, fetal, and placental antecedent determinants.
Diagnosis is a process that identifies, explains, or establishes the individual’s disease from its symptoms and signs. Early and precise diagnosis is crucial since it influences the efficacy of treatment and avoids longterm complications for the infected person. Further, in the case of infectious diseases, undiagnosed patients can transmit the disease to a healthy population unknowingly. Besides, most of the diseases evolve with the time that significantly affects the clinical outcomes.
Multidirectional Benefits of Nanotechnology in the Diagnosis, Treatment and Prevention of Tuberculosis
Despite the curious advancement in medical science and therapeutics, tuberculosis (TB) persist the primary factor of mortality than any other infectious disease and socioeconomic disaster for millions of people around the world. According to the World Health Organization (WHO), World’s One-third of the population is infected with this disease and of these, 8 to 10 million people develop active disease and 2 million people die each year and the rest of the infected people remain asymptomatic.
The Clinical Utility of Outpatient Continuous Glucose Monitoring in Establishing Insulinoma Diagnosis in a Patient with Impaired Nocturnal Hypoglycemia Awareness
Insulinomas are insulin secreting tumors arising from spontaneous mutations of the ductal, acinar, or islet cells of the pancreas. They are rare, having an incidence of only four cases per million people per year. Patients typically present with fasting hypoglycemia, experiencing neurologic symptoms like confusion, changes in vision, or abnormal behavior and autonomic symptoms like palpitations, diaphoresis, or tremulousness.
Immune checkpoint inhibitors (ICIs) are a new type of broad-spectrum antitumor drugs, which mainly include cytotoxic T-lymphocyte-associated protein-4 (CTLA-4) inhibitors, programmed cell death protein-1 (PD-1) and its ligand PD-L1 inhibitors. Since 2011, ICIs have been approved for more than 20 kinds of malignant tumors.